Industry News - BioPharm International


Industry News
The latest news about industry suppliers, business activities, people.

Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

April 23, 2014

Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.

Eli Lilly's Cyramza Receives FDA Approval for Treatment of Advanced Gastric Cancer

April 22, 2014

Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.

Aastrom Biosciences Acquires Sanofi's Cell Therapy and Regenerative Medicine Business

April 21, 2014

Aastrom Biosciences will acquire Sanofi's CTRM business for $6.5 million.

DepoVax Technology Selected for HPV–related Cancer Trials

April 17, 2014

Immunovaccine's vaccine technology chosen for cervical, head, and neck cancer trials conducted by Dana-Farber Institute.

Novartis's Bexsero Receives FDA Breakthrough Therapy Designation

April 17, 2014

Novartis receives FDA breakthrough therapy designation for Bexsero, a meningitis B vaccine.

PolyTherics and MacroGenics Extend ADC Collaboration

April 11, 2014

ThioBridge linker technology to attach different payloads to a range of antibodies

Desktop Human Body Developed for Toxicity Testing

April 10, 2014

The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.

uniQure Announces Management Changes

April 10, 2014

uniQure appoints a new COO and vice president, Medical affairs.

Lilly To Release Data Targeting Key Cancer Pathways At AACR 2014

April 7, 2014

Eli Lilly will present early-stage data regarding cancer therapies at AACR 2014.



Click here